Background: It has long been observed that there are families in which non-medullary thyroid cancer (NMTC) occurs, but few syndromes and genes have been described to date. Proteins in the shelterin complex have been implied in cancer. Here, we have studied shelterin genes in families affected by NMTC (FNMTC).

Methods: We performed whole-exome sequencing (WES) in 10 affected individuals from four families with at least three affected members. Polymerase chain reaction (PCR) and Sanger sequencing were performed to search for variants in the gene in 40 FNMTC families. TINF2 transcripts and loss of heterozygosity (LOH) were studied in several affected patients of one family.

Results: We found the c.507G>T variant in heterozygosis in the gene in one family, co-segregating in all five affected members. This variant affects the normal splicing. LOH was not observed.

Conclusions: Our results reinforce the gene as a susceptibility cause of FNMTC suggesting the importance of location of frameshift variants in . According to our data and previous literature, pathogenic variants appear to be a significant risk factor for the development of NMTC and/or melanoma.

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmg-2024-110185DOI Listing

Publication Analysis

Top Keywords

non-medullary thyroid
8
thyroid cancer
8
novel truncating
4
truncating germline
4
germline variant
4
variant reinforces
4
reinforces susceptibility
4
gene
4
susceptibility gene
4
gene familial
4

Similar Publications

Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers.

Curr Opin Endocr Metab Res

December 2024

Human thyroid cancers preclinical and translational research program, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Thyroid cancer treatment has recently been revolutionized by the introduction of specific targeted therapies (e.g. BRAF or highly selective RET inhibitors), anti-angiogenic agents (e.

View Article and Find Full Text PDF

Background: It has long been observed that there are families in which non-medullary thyroid cancer (NMTC) occurs, but few syndromes and genes have been described to date. Proteins in the shelterin complex have been implied in cancer. Here, we have studied shelterin genes in families affected by NMTC (FNMTC).

View Article and Find Full Text PDF

Objective: Patients with non-medullary thyroid carcinoma (NMTC) that are refractory to radioactive iodine (RAI) have a poor prognosis. Strategies for restoring the ability to take up iodine, so-called redifferentiation, are promising but not suitable for all patients. Preclinical studies, in human cell lines just as in a murine model, have shown that the cardiac glycoside digoxin restored RAI uptake.

View Article and Find Full Text PDF

Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer.

Front Oncol

March 2024

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Familial non-medullary thyroid carcinoma (FNMTC) is a type of thyroid cancer characterized by genetic susceptibility, representing approximately 5% of all non-medullary thyroid carcinomas. While some cases of FNMTC are associated with familial multi-organ tumor predisposition syndromes, the majority occur independently. The genetic mechanisms underlying non-syndromic FNMTC remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!